Keyphrases
Colorectal Cancer Patients
100%
Fistula Formation
100%
Bevacizumab
100%
Postoperative Colorectal Cancer
100%
Fistula
58%
Metastatic Colorectal Cancer (mCRC)
25%
Bevacizumab Therapy
16%
Bevacizumab Treatment
16%
Fistula Repair
16%
Vascular Endothelial Growth Factor
8%
Delayed Diagnosis
8%
Colorectal Cancer
8%
Monoclonal Antibody
8%
Colon Cancer
8%
Anti-angiogenesis
8%
Adverse Events
8%
Consecutive Patients
8%
Resection
8%
Fecal Diversion
8%
Antibody Targeting
8%
Patient Charts
8%
Bowel Perforation
8%
Venous Thromboembolism
8%
Poor Wound Healing
8%
Advanced Colorectal Cancer
8%
Adjuvant Chemotherapy Regimens
8%
Cancer 2
8%
Timing of Operation
8%
Postsurgical Complications
8%
Synchronous Colorectal Cancer
8%
Medicine and Dentistry
Colorectal Cancer
100%
Fistula
100%
Bevacizumab
100%
Metastatic Colorectal Cancer
18%
Adverse Event
6%
Wound Healing
6%
Vasculotropin
6%
Colon Cancer
6%
Monoclonal Antibody
6%
Angiogenesis Inhibitor
6%
Adjuvant Chemotherapy
6%
Surgery
6%
Postoperative Complication
6%
Identified Patient
6%
Intestine Perforation
6%
Venous Thromboembolism
6%
Rectum Cancer
6%
Chemotherapy Regimens
6%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Cancer
100%
Fistula
100%
Bevacizumab
100%
Metastatic Colorectal Cancer
18%
Adverse Event
6%
Wound Healing
6%
Colon Cancer
6%
Monoclonal Antibody
6%
Angiogenesis Inhibitor
6%
Vasculotropin
6%
Venous Thromboembolism
6%
Postoperative Complication
6%
Intestine Perforation
6%
Rectum Cancer
6%
Chemotherapy Regimens
6%